Weight Reduction Versus liraglutide, tirzepatide 5, 10 and 15 mg were associated with statistically greater percentage (%) and absolute (kg) weight reductions, with mean differences [MD] of 7.52%, 12.86% and 13.95%, respectively (Fig
At Yorktown Health, we help patients manage both their diabetes and digestive health
Yellow : Yellowish stool can be associated with oily and greasy foods, which should be avoided on GLP-1s
The most common side effects of GLP-1 drugs are gastrointestinal, such as nausea, vomiting, and diarrhea
In terms of metabolic outcomes, semaglutide consistently outperforms exenatide in both glycemic control and weight reduction across comparison studies
doi:10.1016/S0140-6736(23)01053-X PubMed: This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies